Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Combining fractional CO₂ laser with type III collagen improves acne scar treatment.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.